GlassScriptPhysician profile
Nathan Tanoue
NPI 1922590447
$703.71
in general payments reported to CMS, 2019-2025
6 companies · $242 in 2025
The $242 reported for 2025 was more than what a typical Surgical Critical Care provider received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $70.43 · 2022: $53.22 · 2023: $139 · 2024: $199 · 2025: $242.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $580.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $580.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avita Medical Americas, LLC | $223.82 | 2024-2025 | Cohealyx, Recell, Permeaderm |
| Integra Lifesciences Corporation | $156.46 | 2023-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Medtronic, INC. | $123.00 | 2022-2024 | Signia |
| Polynovo North America LLC | $90.36 | 2025 | Novosorb Btm |
| Boston Scientific Corporation | $70.43 | 2021 | |
| Silk Road Medical, INC. | $39.64 | 2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Tanoue listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.